Sm29, but Not Sm22.6 Retains its Ability to Induce a Protective Immune Response in Mice Previously Exposed to a Schistosoma mansoni Infection

The development of a vaccine against schistosomiasis together with chemotherapy would have a great impact in the disease control and elimination. Sm29 and Sm22.6 are two promising antigens that have been associated with resistance to infection/reinfection in humans and also successfully induce prote...

Full description

Bibliographic Details
Main Authors: Alves, Clarice Carvalho, Araujo, Neusa, dos Santos, Viviane Cristina Fernandes, Couto, Flávia Bubula, Assis, Natan R. G., Morais, Suellen B., Oliveira, Sérgio Costa, Fonseca, Cristina Toscano
Format: Online
Language:English
Published: Public Library of Science 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4344193/